Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGS2 | P35354 | 3/20 | 0.46 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.41 |
| ▸ | TSHR | P16473 | 1/20 | 0.41 |
| ▸ | CA2 | P00918 | 3/20 | 0.40 |
| ▸ | CA1 | P00915 | 2/20 | 0.40 |
| ▸ | TNFRSF1A | P19438 | 2/20 | 0.39 |
| ▸ | DHFR | P00374 | 1/20 | 0.38 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.38 |
| ▸ | LMNA | P02545 | 1/20 | 0.38 |
| ▸ | TP53 | P04637 | 1/20 | 0.38 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.38 |
| ▸ | HPGD | P15428 | 1/20 | 0.38 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.34 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.34 |
| ▸ | ADRA1D | P25100 | 1/20 | 0.34 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.34 |
| ▸ | ADRA1B | P35368 | 1/20 | 0.34 |
| ▸ | CA4 | P22748 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL351682 | 0.89 | PTGS2 (0.39) | PTGS2PTGS1ALDH1A1TDP1TSHR | |
| SCHEMBL482502 | 0.86 | CA2 (0.45) | PTGS2PTGS1ALDH1A1TDP1TSHR | |
| SCHEMBL699612 | 0.86 | DHFR (0.37) | PTGS2PTGS1ALDH1A1TDP1TSHR | |
| SCHEMBL6766393 | 0.81 | MCL1 (0.41) | PTGS2PTGS1ALDH1A1TDP1TSHR | |
| SCHEMBL703552 | 0.78 | ALDH1A1 (0.59) | PTGS2ALDH1A1TDP1TSHRALOX15 | |
| SCHEMBL5857102 | 0.78 | ALDH1A1 (0.52) | PTGS2PTGS1ALDH1A1TDP1TSHR | |
| SCHEMBL2947022 | 0.78 | PTGS2 (0.47) | PTGS2PTGS1ALDH1A1TDP1TSHR | |
| SCHEMBL22360314 | 0.78 | CA1 (0.64) | PTGS2PTGS1ALDH1A1TDP1TSHR | |
| SCHEMBL6668536 | 0.76 | PTGS2 (0.46) | PTGS2PTGS1ALDH1A1TDP1TSHR | |
| SCHEMBL11743999 | 0.76 | PTGS2 (0.46) | PTGS2PTGS1ALDH1A1TDP1TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4257582-A1 | FUEL CELL WITH POLYMER ELECTROLYTE MEMBRANE | Hyundai Mobis Co., Ltd. (KR) | 2023-10-11 | — | — | EP | disclosed |
| EP-4089097-A1 | PREPARATION METHOD FOR AND APPLICATION OF CHIRAL SPIROCYCLIC PHOSPHINE-NITROGEN-PHOSPHINE TRIDENTATE LIGAND AND IRIDIUM CATALYST THEREOF | Zhejiang Jiuzhou Pharmaceutical Co., Ltd (CN) | 2022-11-16 | — | — | EP | disclosed |
| WO-2021139499-A1 | PREPARATION METHOD FOR AND APPLICATION OF CHIRAL SPIROCYCLIC PHOSPHINE-NITROGEN-PHOSPHINE TRIDENTATE LIGAND AND IRIDIUM CATALYST THEREOF | 浙江九洲药业股份有限公司 | 2021-07-15 | — | — | WO | disclosed |
| US-8148519-B2 | Porphyrin-based photosensitizer dyes for dye-sensitized solar cells | NATIONAL CHIAO TUNG UNIVERSITY (TW) | 2012-04-03 | — | — | US | disclosed |
| US-20100125136-A1 | PORPHYRIN-BASED PHOTOSENSITIZER DYES FOR DYE-SENSITIZED SOLAR CELLS | DC SOLAR CORP. A TAIWAN CORPORATION (TW) | 2010-05-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100125136-A1 | PORPHYRIN-BASED PHOTOSENSITIZER DYES FOR DYE-SENSITIZED SOLAR CELLS | DNAH12, SLC39A3, CRY1 | PTGS2 4336/4885PTGS1 4505/4885ALDH1A1 2030/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.